Arul Joseph

Arul Joseph has extensive experience in pharmaceutical development, serving as Senior Director at Otsuka Pharmaceutical Companies (U.S.) from January 2020 to December 2021, where responsibilities included leading drug substance development and manufacturing as well as overseeing CMC program activities for various compounds. Prior to this, Arul held senior roles in pharmaceutical development at Avanir Pharmaceuticals and Gilead Sciences, focusing on formulation, process, chemical, and analytical development. Arul's career includes significant positions at Sanofi, Merck, and Fish & Richardson, contributing to R&D in oncology and anti-infectives, and conducting patent due diligence for an IPO. Arul holds an MBA in Strategy and Finance from NYU Stern School of Business and a Ph.D. in Organic Chemistry from the University of Maryland.